1. Australia signs two more COVID-19 vaccine agreements  Sydney Morning Herald
  2. Two more potential coronavirus vaccines secured for Australia, Federal Government says  ABC News
  3. Scott Morrison to announce two new COVID vaccine deals  The Conversation AU
  4. A Covid Vaccine Is the Next Tourist Attraction  Bloomberg
  5. Government buys up millions of doses of COVID-19 vaccine  Herald Sun
  6. View Full coverage on Google News
Australia has secured 50 million more potential coronavirus vaccine doses through two new agreements.Australia has secured 50 million more potential coronavirus vaccine doses through two new agreements.

The Federal Government says it has secured deals for two more potential coronavirus vaccines that would deliver another 50 million doses to the Australian public.The Federal Government says it has secured deals for two more potential coronavirus vaccines that would deliver another 50 million doses to the Australian public.

iview

Category: <span> </span> | Herald Sun

The government has secured deals for two further COVID-19 vaccines, taking its portfolio of agreements to four.The government has secured deals for two further COVID-19 vaccines, taking its portfolio of agreements to four.

Scott Morrison to announce two new COVID vaccine deals

Scott Morrison to announce two new COVID vaccine deals

The federal government has signed two new deals giving Australia more access to coronavirus vaccines early next year. The Coalition secured another 50 million doses of vaccine candidates from Novavax and Pfizer, should they be proven safe and effective through clinical trials. The deals build on existing commitments to purchase the University of Oxford vaccine and a local candidate from the University of Queensland. Health Minister Greg Hunt says the government is "strengthening" its investments, giving Australians the best shot at early access to a vaccine. The federal government has signed two new deals giving Australia more access to coronavirus vaccines early next year. The Coalition secured another 50 million doses of vaccine candidates from Novavax and Pfizer, should they be proven safe and effective through clinical trials. The deals build on existing commitments to purchase the University of Oxford vaccine and a local candidate from the University of Queensland. Health Minister Greg Hunt says the government is "strengthening" its investments, giving Australians the best shot at early access to a vaccine.

The federal government will buy 40million doses of a vaccine produced by American company Novavax and 10million doses of one jointly produced by US firms Pfizer and BioNTech.The federal government will buy 40million doses of a vaccine produced by American company Novavax and 10million doses of one jointly produced by US firms Pfizer and BioNTech.

Covid-19: Scott Morrison buys 50 million doses of two more vaccines | Daily Mail Online

Bloomberg - Are you a robot?

Rather than fixing US’ cumbersome vaccine approval and distribution system, the government might find it easier to encourage an allied nation to offer their product to visiting Americans.Rather than fixing US’ cumbersome vaccine approval and distribution system, the government might find it easier to encourage an allied nation to offer their product to visiting Americans.

'Vaccine tourism' could see Americans flying out to get Covid shot early

Rather than fixing US’ cumbersome vaccine approval and distribution system, the government might find it easier to encourage an allied nation to offer their product to visiting Americans.Rather than fixing US’ cumbersome vaccine approval and distribution system, the government might find it easier to encourage an allied nation to offer their product to visiting Americans.

'Vaccine tourism' could see Americans flying out to get Covid shot early

Every Australian would be able to get a COVID vaccine before the end of 2021, the federal government says, with two new deals with Pfizer and Novavax.Every Australian would be able to get a COVID vaccine before the end of 2021, the federal government says, with two new deals with Pfizer and Novavax.

Australia locks in two new coronavirus vaccine candidate deals

Australia joins a growing list of countries that have locked in orders for NVX-CoV2373.Australia joins a growing list of countries that have locked in orders for NVX-CoV2373.

Novavax to Provide 40 Million Doses of Its COVID-19 Vaccine Candidate to Australia | The Motley Fool

SHANGHAI/BANDUNG, Indonesia -- Starting at noon on select days, green hospital curtains go up on the windows and doors of a Puskesmas -- a spare, goveSoutheast Asia bargains with Beijing for lifesaving drugs

Red Pill? Behind China's COVID-19 vaccine diplomacy - Nikkei Asia

The programme will be using a shot developed by Chinese state-owned pharmaceutical firm Sinopharm, which is in Phase III trials in the UAE, Egypt, Bahrain and Jordan.Bahrain's Health Minister Faeqa bint Saeed Al Saleh said that the use of the coronavirus vaccine complies with the country's regulations on exceptional licensing in emergency casesThe programme will be using a shot developed by Chinese state-owned pharmaceutical firm Sinopharm, which is in Phase III trials in the UAE, Egypt, Bahrain and Jordan.Bahrain's Health Minister Faeqa bint Saeed Al Saleh said that the use of the coronavirus vaccine complies with the country's regulations on exceptional licensing in emergency cases

Coronavirus vaccine: Bahrain frontline workers receive shots of Covid-19

DUBAI: Bahrain has granted emergency approval for the use of a COVID-19 vaccine candidate on frontline workers from Tuesday, state news agency BNA said, reporting an announcement by the health minister. The United Arab Emirates in September allowed similar emergency use of the same vaccine for frontline workers at high risk of infection with the new coronavirus.DUBAI: Bahrain has granted emergency approval for the use of a COVID-19 vaccine candidate on frontline workers from Tuesday, state news agency BNA said, reporting an announcement by the health

Bahrain announces emergency approval for use of COVID-19 vaccine candidate | Arab News

The Department of Health (DOH) on Tuesday said 1,772 more people were confirmed to have been infected with COVID-19, bringing the total number of active cases to 30,876.The Department of Health (DOH) on Tuesday said 1,772 more people were confirmed to have been infected with COVID-19, bringing the total number of active cases to 30,876.

New COVID-19 cases fall below 2,000 | Inquirer News

China News: Chinese companies have made a seemingly unstoppable push to the front of the race for a coronavirus vaccine. Yet their speedy ascent has been unhinderChina News: Chinese companies have made a seemingly unstoppable push to the front of the race for a coronavirus vaccine. Yet their speedy ascent has been unhinder

China Coronavirus Vaccine: China’s race for Covid-19 vaccine raises safety questions | World News - Times of India

By Francesco Guarascio BRUSSELS (Reuters) - Europe's drug regulator will not set a minimum level of efficacy for potential COVID-19 vaccines when considering them for approval, it said on Wednesday, taking a different approach to that of its U.S. counterpart. Human studies need to demonstrate a convincing level of efficacy, but whether a shot would be considered acceptable for approval will be assessed case by case based on all available data on its safety and efficacy, the European Medicines Agency (EMA) said in an email. Therefore it is not possible to specifically quantify in advance the minimum level of efficacy for a vaccine to be considered acceptable for approval, it said. The U.S. Food and Drug Administration has said vaccines must demonstrate at least 50% efficacy - meaning at least twice as many infections among volunteers who got a placebo as among those in the vaccine group. The EMA is reviewing candidate vaccines by drug makers Pfizer, AstraZeneca and Moderna under a real-time release process, in an effort to speed up the approval if trials of any of those vaccines are successful. They are undergoing late-stage trials. The EMA said on Wednesday its human medicines committee (CHMP) is drawing up guidance on its requirements for COVID-19 vaccine approval and will publish the information as soon as it is ready. (Reporting by Francesco Guarascio in Brussels @fraguarascio; Writing by Josephine Mason in London, editing by Emelia Sithole-Matarise)By Francesco Guarascio BRUSSELS (Reuters) - Europe's drug regulator will not set a minimum level of efficacy for potential COVID-19 vaccines when considering them for approval, it said on Wednesday, taking a different approach to that of its U.S. counterpart. Human studies need to demonstrate a convincing level of efficacy, but whether a shot would be considered acceptable for approval will be assessed case by case based on all available data on its safety and efficacy, the European Medicines Agency (EMA) said in an email. "Therefore it is not possible to specifically quantify in advance the minimum level of efficacy for a vaccine to be considered acceptable for approval," it said. The U.S. Food and Drug Administration has said vaccines must demonstrate at least 50% efficacy - meaning at least twice as many infections among volunteers who got a placebo as among those in the vaccine group. The EMA is reviewing candidate vaccines by drug makers Pfizer, AstraZeneca and Moderna under a real-time release process, in an effort to speed up the approval if trials of any of those vaccines are successful. They are undergoing late-stage trials. The EMA said on Wednesday its human medicines committee (CHMP) is drawing up guidance on its requirements for COVID-19 vaccine approval and will publish the information as soon as it is ready. (Reporting by Francesco Guarascio in Brussels @fraguarascio; Writing by Josephine Mason in London, editing by Emelia Sithole-Matarise)

'This is not a job for one Superman. He has to assemble his Justice League,' says Senate President Pro Tempore Ralph Recto, who earlier suggested the appointment of a COVID-19 'vaccine czar' 'This is not a job for one Superman. He has to assemble his Justice League,' says Senate President Pro Tempore Ralph Recto, who earlier suggested the appointment of a COVID-19 'vaccine czar'

CHICAGO — The University of Chicago Medical Center will serve as a testing site for Janssen Pharmaceutical’s Phase 3 clinical research study to evaluate the safety and efficacy of Janssen’s investigational COVID-19 vaccine candidate. The randomized, double-blind placebo controlled clinical trial is designed to evaluate the vaccine’s safety and efficacy in a single dose. The […]CHICAGO — The University of Chicago Medical Center will serve as a testing site for Janssen Pharmaceutical’s Phase 3 clinical research study to evaluate the safety and efficacy of Janssen&#82…

University of Chicago begins recruiting for Phase 3 COVID-19 investigational clinical trial | WGN-TV

Tulane University School of Medicine is a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase III clinical research study of a COVID-19 vaccine known as Ad26Tulane University School of Medicine will be a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase III clinical research study of a new COVID-19 vaccine.

Tulane begins recruiting for Janssen COVID-19 vaccine study | Tulane News

Aspen Pharmacare’s Port Elizabeth factory can produce up to 300-million doses a year of a Covid-19 vaccine candidate that could turn the tide in the fight against the coronavirus.Aspen Pharmacare’s Port Elizabeth factory can produce up to 300-million doses a year of a Covid-19 vaccine candidate that could turn the tide in the fight against the coronavirus.

Aspen in line to be global supplier of vaccine

Preparation is ongoing for the roll-out of any Covid-19 vaccine.Preparation is ongoing for the roll-out of any Covid-19 vaccine.

Nightingale hospitals to become mass vaccination centres – NHS | Express & Star

The government is eyeing massive COVID-19 immunization activities early next year – to be done in two doses 21 days apart.The government is eyeing massive COVID-19 immunization activities early next year – to be done in two doses 21 days apart.

Vaccine czar presents 2-dose, 3-week plan | Philstar.com

GPs will be paid for administering a Covid vaccine under a scheme due to start next month, in the latest sign that the NHS is gearing up for a jab to become available before the year ends.FamilyGPs will be paid for administering a Covid vaccine under a scheme due to start next month, in the latest sign that the NHS is gearing up for a jab to become available before the year ends.Family

There is no guarantee that Novavax's Covid-19 vaccine work will be a success and that uncertainty means increased choppiness in NVAX stockInvestors in NVAX stock could see further price volatility in the rest of the year

NVAX Stock May Come Under Pressure Unless There's a Working Vaccine | InvestorPlace

The Coalition for Epidemic Preparedness Innovation (CEPI) said on Tuesday it will fund the development of the protein-based S-Trimer COVID-19 vaccine candidate by China's Clover Biopharmaceuticals Inc.The Coalition for Epidemic Preparedness Innovation (CEPI) said on Tuesday it will fund the development of the protein-based S-Trimer COVID-19 vaccine candidate by China's Clover Biopharmaceuticals Inc.

CEPI to fund development of COVID-19 vaccine candidate by China's Clover | Reuters

FAMILY doctors are being told to prepare for a Covid-19 vaccine roll-out early next month. And in further good news Chief Medical Officer Professor Chris Whitty, raised hopes of families being able to spend Christmas together.FAMILY doctors are being told to prepare for a Covid-19 vaccine roll-out early next month. And in further good news Chief Medical Officer Professor Chris Whitty, raised hopes of families being able to spend Christmas together.

Coronavirus vaccine: Family doctors told to prepare for Covid vaccine roll-out next month | UK | News | Express.co.uk

Authorisation comes as part of coordination with UAE, health minister saysAuthorisation comes as part of coordination with UAE, health minister says

COVID-19: Bahrain allows use of vaccine for health workers | Bahrain – Gulf News

The North Florida/South Georgia Veterans Health System began a clinical trial Tuesday for a single-dose investigational COVID-19 vaccine.The North Florida/South Georgia Veterans Health System began a clinical trial Tuesday for a single-dose investigational COVID-19 vaccine.

North Florida/South Georgia COVID-19 vaccine clinical trial seeks volunteers

BERLIN: Germany is scouting trade fair halls and airport terminals to use as potential mass vaccination centres, as it draws up plans to inoculate ...BERLIN: Germany is scouting trade fair halls and airport terminals to use as potential mass vaccination centres, as it draws up plans to inoculate ...

Germany readies exhibition halls, mobile teams for COVID-19 vaccination - CNA

Novavax Inc said on Wednesday it has signed an agreement with the Australian government to supply 40 million doses of its COVID-19 vaccine candidate, NVX-CoV2373.Novavax Inc said on Wednesday it has signed an agreement with the Australian government to supply 40 million doses of its COVID-19 vaccine candidate, NVX-CoV2373.

Novavax to supply 40 million doses of COVID-19 vaccine to Australia | Article [AMP] | Reuters

Bahrain has officially approved a COVID-19 vaccineBahrain has officially approved a COVID-19 vaccine

Bahrain approves COVID-19 vaccine for frontline workers - Times of Oman

Coronavirus vaccine update: Scientists have developed a new vaccine candidate that generates much more antibodies and better immune response in animals. Meanwhile, J&J vaccine trials have resumed in Brazil and Mexico has received Chinese firm CanSino Biologics' drug for late-stage trials.Coronavirus vaccine update: Scientists have developed a new vaccine candidate that generates much more antibodies and better immune response in animals. Meanwhile, J&J vaccine trials have resumed in Brazil and Mexico has received Chinese firm CanSino Biologics' drug for late-stage trials.

Coronavirus vaccine update: Scientists develop ‘ultrapotent’ vaccine candidate, J&J resumes trial in Brazil - Coronavirus Outbreak News

Health minister Zweli Mkhize has praised Aspen Pharmacare's plans to partner with Johnson & Johnson to manufacture, package and distribute a candidate Covid-19 vaccine locally, once it was successfully registered in the country.Health minister Zweli Mkhize has praised Aspen Pharmacare's plans to partner with Johnson & Johnson to manufacture, package and distribute a candidate Covid-19 vaccine locally, once it was successfully registered in the country.

Mkhize hails plans to manufacture and distribute Covid-19 vaccine locally

'Managerial skills' are needed to facilitate the distribution of the future novel coronavirus vaccine, Malacañang said Tuesday, as it sought justify President Rodrigo Duterte's choice of an ex-general instead of a medical expert to lead immunization against the pandemic.  'Managerial skills' are needed to facilitate the distribution of the future novel coronavirus vaccine, Malacañang said Tuesday, as it sought justify President Rodrigo Duterte's choice of an ex-general instead of a medical expert to lead immunization against the pandemic. 

Why is COVID-19 vaccine czar an ex-general? 'Managerial skills' needed, says Palace | ABS-CBN News

One thousand Bay Area volunteers could represent the leading edge in the race to create a COVID-19 vaccine. Stanford University is using the group as part of the final stage trials on a virus vaccine.One thousand Bay Area volunteers could represent the leading edge in the race to create a COVID-19 vaccine. Stanford University is using the group as part of the final stage trials on a virus vaccine.

Germany is scouting trade fair halls and airport terminals to use as potential mass vaccination centresGermany is scouting trade fair halls and airport terminals to use as potential mass vaccination centres

Germany readies exhibition halls as mass vaccination centres for Covid-19

Currently, there are 11 vaccines which have reached the final stage of testing, this stage is critical because if the vaccine were to fail, it would be at this stageCurrently, there are 11 vaccines which have reached the final stage of testing, this stage is critical because if the vaccine were to fail, it would be at this stage

How close are we to a COVID-19 vaccine?

The drug company’s effort is one of several large experiments under way in the Bay Area. <p><underscore class="character" displayname="underscore" name="underscore" xmlns:cci="urn:schemas-ccieurope.com">The drug company’s effort is </underscore>one of several large experiments <underscore class="character" displayname="underscore" name="underscore" xmlns:cci="urn:schemas-ccieurope.com">under way</underscore> in the Bay Area.</p>

Stanford to enroll 1,000 volunteers for Johnson & Johnson coronavirus vaccine trial - SFChronicle.com

As the world continues on in the race to find a COVID-19 vaccine, Stanford Medicine is doing its part too.As the world continues on in the race to find a COVID-19 vaccine, Stanford Medicine is doing its part too.

Stanford joins COVID-19 vaccine trial | KRON4

National Task Force Against COVID-19 Chief Implementer Carlito Galvez Jr. now has another title: vaccine czar.National Task Force Against COVID-19 Chief Implementer Carlito Galvez Jr. now has another title: vaccine czar.

Galvez is confirmed as vaccine czar

Stanford Medicine is now part of a Phase 3 clinical trial for a possible vaccine for COVID-19.The vaccine is from a Johnson & Johnson subsidiary.

Stanford Medicine joins promising Johnson & Johnson COVID-19 vaccine trials, recruiting volunteers | abc7news.com

President Rodrigo Duterte has assigned Secretary Carlito Galvez Jr. as the government point person to negotiate for the procurement and distribution of COVID-19 vaccines in the country.President Rodrigo Duterte has assigned Secretary Carlito Galvez Jr. as the government point person to negotiate for the procurement and distribution of COVID-19 vaccines in the country.

Duterte: Galvez lone negotiator for procurement of COVID-19 vaccines